UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korean Covid-19 vaccine, treatment candidates effective in monkeys
Genexine’s investigational Covid-19 vaccine and Celltrion’s treatment candi...
by Kim Chan-hyuk
|
2020-08-20 13:45
라인
Hanmi to present study on fatty liver drugs in Europe
Hanmi Pharmaceutical said Tuesday that the company would present its recent...
by Shim Hyun-tai
|
2020-08-19 16:13
라인
Jaytech Biogen punished for omitting report of sex hormone drugs supply
The Ministry of Food and Drug Safety said it has imposed an administrative ...
by Kim Chan-hyuk
|
2020-08-19 15:15
라인
Bridge Bio shares plummet on possible cancellation of ₩1.5-trillion deal
Bridge Biotherapeutics shares tanked on Wednesday, as the company did not r...
by Lee Han-soo
|
2020-08-19 13:07
라인
Philosys’ sample collection kit wins FDA nod
Philosys, an affiliate of Philosys Healthcare, said Tuesday that it has won...
by Shim Hyun-tai
|
2020-08-18 18:21
라인
LG Chem licenses in NASH treatment candidate from China
LG Chem said that it has licensed in TT-01025, a non-alcoholic steatohepati...
by Lee Han-soo
|
2020-08-18 15:18
라인
Medytox shares resurge as court allows sales resumption of Meditoxin
Medytox's shares hit its upper limits on Tuesday, as a local court acce...
by Lee Han-soo
|
2020-08-18 15:18
라인
GC Labcell confirms efficacy of NK cell therapy in treating Covid-19
GC Labcell said that it has confirmed the efficacy of its natural killer (N...
by Lee Han-soo
|
2020-08-18 15:10
라인
MSD Korea’s spinoff Organon Korea to settle in Gwanghwamun
Organon Korea, a spinoff from MSD Korea, will use a shared office in Gwangh...
by Kim Yun-mi
|
2020-08-18 11:39
라인
SK Bioscience inks CDMO deal with Novavax for Covid-19 vaccine
SK Bioscience, a subsidiary of SK Chemical, has signed a CDMO (contract dev...
by Lee Han-soo
|
2020-08-14 15:36
라인
Covid-19 makes Vivozon halt P3 trial of nonnarcotic analgesics in US
said that it has halted its phase 3b clinical trials for using opiranserin,...
by Lee Han-soo
|
2020-08-13 17:27
라인
Takeda expects more effective IBD treatment with Kynteles' expanded reimbursement
Takeda Korea is strengthening its position in the domestic inflammatory bow...
by Lee Han-soo
|
2020-08-12 17:45
라인
Roche’s Tecentriq-Avastin combo wins nod to treat hepatocellular carcinoma
Roche has become the first company in Korea to win the regulator’s nod to u...
by Lee Han-soo
|
2020-08-12 14:35
라인
Daewoong to conduct P1 trial of Covid-19 treatment in India
Daewoong Pharmaceutical said that the Indian health regulators have approve...
by Lee Han-soo
|
2020-08-11 17:48
라인
Curocell draws $37-million investment, steps up trials of CAR-T therapy
Curocell, Korea’s first developer of chimeric antigen receptor T (CAR-T) ce...
by Park Gi-taek
|
2020-08-10 17:28
라인
Rheumatoid arthritis drug Rinvoq gets insurance benefit
AbbVie Korea’s rheumatoid arthritis treatment Rinvoq SR Tab. 15mg (ingredie...
by Kim Eun-young
|
2020-08-07 14:34
라인
Regulator OKs Pfizer's BRCA mutation breast cancer treatment
Pfizer Korea said that the Ministry of Food and Drug Safety has approved Ta...
by Lee Han-soo
|
2020-08-05 16:02
라인
Hanmi, MSD sign licensing agreement for hepatitis treatment
Hanmi Pharmaceutical said it has entered into an exclusive licensing agreem...
by Shim Hyun-tai
|
2020-08-05 15:24
라인
Korean biopharmaceutical market expands on biosimilar export growth
The domestic biopharmaceutical market grew last year, mainly boosted by exp...
by Kim Chan-hyuk
|
2020-08-04 15:46
라인
Medpacto to unveil trial results at European conference
Medpacto, a biomarker-based new drug developer, said it would present the p...
by Lee Han-soo
|
2020-08-04 14:44
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top